Advisory Board | Legion Healthcare Partners

Meet Our Advisory Board


Our Advisory Board


Joe Chang, MD, PhD, FASTRO

Tenured Professor

Director of Stereotactic Ablative Radiotherapy

MD Anderson Cancer Center

About Joe

Dr. Chang is the Fellow of American Society of Radiation Oncology and received the award of The Best Doctors in America. He is the current chair for American Radium Society/American College of Radiology (ACR) Thoracic Appropriateness Use Criteria Committee, chair of thoracic subcommittee of international Particle Therapy Co-Operative Group (PTCOG), NCCN Thoracic Guidelines Voting Committee Member.


Sameer R. Keole, MD

Medical Director
Proton Therapy Center
at Mayo Clinic

About Sameer

Dr. Keole is Medical Director of the Proton Beam Therapy program at the Mayo Clinic in Arizona where he also serves as consultant. He is an assistant professor of radiation oncology at Mayo Clinic College of Medicine.


Ritsuko Komaki, MD, FACR, FASTRO

Emeritus Professor of Radiation Oncology at the University of Texas
MD Anderson Cancer Center

Adjunct Professor of Radiation Oncology and Scientific Research Departments at
Baylor College of Medicine

About Dr. Komaki

Dr. Komaki is an Emeritus Professor of Radiation Oncology at the University of Texas M.D. Anderson Cancer Center in Houston and held the Gloria LuptonTennison Distinguished Professorship in Lung Cancer Research. She received her medical degree from Hiroshima University School of Medicine, Hiroshima, Japan, and completed her residency and fellowship in Radiation Oncology at the Medical College of Wisconsin in Milwaukee.


James W. Welsh, MD

Tenured Physician-Scientist

Principal Investigator of Welsh Immunotherapy and Molecular Lab

University of Texas MD Anderson Cancer Center

About Dr. Welsh

James W. Welsh, MD, is a Tenured Physician Scientist at The University of Texas MD Anderson Cancer Center. Dr. Welsh started his oncology career in the Department of Molecular Oncology at Genentech Inc., at an exciting time when some of the first personalized target therapies were developed.


Bob Rich

Chairman, Rich Products Corporation

Chairman Emeritus of the Board of Directors and Trustees of the Cleveland Clinic

About Bob

As Chairman of Rich Products Corporation, Mr. Rich has led the company to more than $4 billion in worldwide sales revenue. Mr. Rich continues to build business in new markets with cutting-edge management practices, high business ethics, and customer service standards, which have earned him distinction as one of the nation’s most prominent business leaders.


John Mascatello

EVP and Managing Executive



About John

Mr. Mascatello joined Wasserman as Executive Vice President & Managing Executive in 2011 as part of Wasserman's acquisition of leading golf representation business, SFX Golf. In this role, Mascatello heads the Golf Division's prominent athlete management, events and golf consulting.

Contact us for more information about our proton therapy solutions, education, business intelligence and oncology consulting services.

Legion Logo White0

By definition, the word Legion means an immeasurable crowd, vast host, multitude or number of people. Our Legion takes the fight against cancer to heart.

  • 2001 Kirby Drive
    Suite 1100
    Houston, Texas


  • 650-600-0001

© 2020 Legion Healthcare Partners
Scroll to Top